Penwest Announces Allowance for Oxymorphone Patent Application Related to OPANA ER
July 23, 2007 12:49 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 23, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported that the U.S. Patent and Trademark Office (PTO) has indicated on its website that a Penwest...
Penwest Second Quarter 2007 Financial Results Conference Call
July 17, 2007 16:36 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 17, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Friday, July 27, at 11:00 a.m. EDT to review its financial results for the...
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
July 17, 2007 06:45 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., July 17, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that it has entered into a research, development, commercialization and license agreement...
Christophe Bianchi, M.D. Named to Penwest Board of Directors
June 25, 2007 08:30 ET
|
Penwest Pharmaceuticals Co.
DANBURY, Conn., June 25, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) announced today that Christophe Bianchi, M.D. has been named to the Company's Board of Directors.
Dr....